Fortsatt vård efter drogmissbruksbehandling: koppling till primärvård (Linkage)
25 april 2023 uppdaterad av: Kaiser Permanente
Den här komponenten i ett större forskningscentrum för Excellence Grant förbättrar behandlingen av drogmissbruk genom att utveckla effektiva kopplingar mellan specialläkemedelsbehandling och primärvård.
Studieöversikt
Status
Aktiv, inte rekryterande
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Detta är en longitudinell tvåarmad kvasi-experimentell 3-månaders alternerande av/på-design under en 30-månadersperiod där, efter en slumpmässig start, kopplingstillståndet växelvis läggs till Vanlig vård på kliniken för kemiskt beroende (CD) och sedan tog bort.
Vi jämför Usual Care med Usual Care plus Länkage.
Uppföljningsintervjuer kommer att genomföras vid 6, 12 och 24 månader.
Länkningsinterventionen inkluderar Usual Care plus 1) sessioner om aktivering angående övergripande hälsobeteenden och om att välja en primärvårdsläkare och kommunicera med honom/henne, och 2) ett länksamtal (och/eller ett underlättat e-postmeddelande) med patienten, läkaren , och primärvårdsläkare.
Interventionen syftar till att sätta drogmissbruksproblem i ett sammanhang med den övergripande hälso- och sjukvården och att aktivera patienter att öka engagemanget i sin egen sjukvård.
Studietyp
Interventionell
Inskrivning (Faktisk)
504
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
California
-
San Francisco, California, Förenta staterna, 94115
- Kaiser Permanente, Chemical Dependency Recovery Program
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
18 år och äldre (Vuxen, Äldre vuxen)
Tar emot friska volontärer
Nej
Beskrivning
Inklusionskriterier:
- Forskningsdeltagare kommer att vara vuxna patienter vid Kaiser Permanente San Francisco Chemical Dependency Recovery Program, som har genomgått 2 veckors behandling.
Exklusions kriterier:
- Patienter med diagnosen demens, mental retardation eller som är aktivt psykotiska eller suicidala kommer att uteslutas av sin läkare.
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Hälsovårdsforskning
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Inget ingripande: Vanlig vård
Vanlig CD-behandling, inklusive terapigrupper och individuella rådgivningssessioner, och sex 45-minuters medicinska utbildningsgrupper.
Läkarbesök, farmakoterapi och SUD-mediciner var tillgängliga vid behov.
|
|
|
Experimentell: Koppla patientaktiveringsintervention
Vanlig vård med undantaget att de sex 45-minuters kopplingsgrupperna för patientaktivering ersatte de sex 45-minuters läkarutbildningsgrupperna i 45 min, plus ett kopplingstelefonsamtal (och/eller ett underlättat e-postmeddelande) med patienten, läkaren och primärvården läkare.
|
Usual Care plus Linkage omfattade Usual Care med undantaget att de sex 45-minuters Linkage-patientaktiveringsutbildningsgrupperna ersatte de sex 45-minutersmedicinska utbildningsgrupperna för Usual Care, plus ett länksamtal (och/eller ett förenklat e-postmeddelande) med patienten, läkare och primärvårdsläkare. Patientaktiveringsinterventionskomponenterna - 1) sex 45-minuters kopplingssessioner om aktivering angående övergripande hälsobeteenden och 2) ett kopplingstelefonsamtal (och/eller ett underlättat e-postmeddelande) med patienten, läkaren och PC-läkaren - levererades av en klinisk psykolog. |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
patientaktiveringsåtgärd
Tidsram: 6 månader efter baslinjen
|
Mäts med Patient Activation Measure (PAM) från intervjudata
|
6 månader efter baslinjen
|
|
patientens engagemang i hälso- och sjukvården (inklusive patientportalanvändning, förtrogenhet och tillfredsställelse med primärvårdsläkare och CD-behandlingslängd på vistelsen)
Tidsram: 6 månader efter baslinjen
|
Mätt med data från intervjuer och elektronisk journal (EPJ)
|
6 månader efter baslinjen
|
|
Missbruk och psykisk hälsa
Tidsram: 6 månader efter baslinjen
|
Åtgärder inkluderar tidigare 30 dagars alkohol, droger och total abstinens; Patient Health Questionnaire (PHQ-9) och Addiction Severity Index med hjälp av intervjudata
|
6 månader efter baslinjen
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
patientaktiveringsåtgärd vid 12 och 24 månader
Tidsram: 12 och 24 månader efter baslinjen
|
Mäts med Patient Activation Measure (PAM) från intervjudata
|
12 och 24 månader efter baslinjen
|
|
patientengagemang i vården vid 12 och 24 månader
Tidsram: 12 och 24 månader efter baslinjen
|
Mätt med data från intervjuer och elektronisk journal (EPJ)
|
12 och 24 månader efter baslinjen
|
|
Missbruk och psykisk hälsa vid 12 och 24 månader
Tidsram: 12 och 24 månader efter baslinjen
|
Åtgärder inkluderar tidigare 30 dagars alkohol, droger och total abstinens; Patient Health Questionnaire (PHQ-9) och Addiction Severity Index med hjälp av intervjudata
|
12 och 24 månader efter baslinjen
|
|
Hälsovårdens utnyttjande och kostnad
Tidsram: 12 och 24 månader efter baslinjen
|
Mätt med data från intervjuer och administrativa data
|
12 och 24 månader efter baslinjen
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Sponsor
Samarbetspartners
Utredare
- Huvudutredare: Constance M Weisner, DrPH, LCSW, Kaiser Permanente
Publikationer och användbara länkar
Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.
Allmänna publikationer
- Willems S, De Maesschalck S, Deveugele M, Derese A, De Maeseneer J. Socio-economic status of the patient and doctor-patient communication: does it make a difference? Patient Educ Couns. 2005 Feb;56(2):139-46. doi: 10.1016/j.pec.2004.02.011.
- Lorig KR, Holman H. Self-management education: history, definition, outcomes, and mechanisms. Ann Behav Med. 2003 Aug;26(1):1-7. doi: 10.1207/S15324796ABM2601_01.
- Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness: the chronic care model, Part 2. JAMA. 2002 Oct 16;288(15):1909-14. doi: 10.1001/jama.288.15.1909.
- Hibbard JH, Stockard J, Mahoney ER, Tusler M. Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res. 2004 Aug;39(4 Pt 1):1005-26. doi: 10.1111/j.1475-6773.2004.00269.x.
- Sterling S, Chi F, Campbell C, Weisner C. Three-year chemical dependency and mental health treatment outcomes among adolescents: the role of continuing care. Alcohol Clin Exp Res. 2009 Aug;33(8):1417-29. doi: 10.1111/j.1530-0277.2009.00972.x. Epub 2009 Apr 30.
- Mertens JR, Lu YW, Parthasarathy S, Moore C, Weisner CM. Medical and psychiatric conditions of alcohol and drug treatment patients in an HMO: comparison with matched controls. Arch Intern Med. 2003 Nov 10;163(20):2511-7. doi: 10.1001/archinte.163.20.2511.
- Weisner C, Mertens J, Parthasarathy S, Moore C, Lu Y. Integrating primary medical care with addiction treatment: a randomized controlled trial. JAMA. 2001 Oct 10;286(14):1715-23. doi: 10.1001/jama.286.14.1715.
- Parthasarathy S, Weisner CM. Five-year trajectories of health care utilization and cost in a drug and alcohol treatment sample. Drug Alcohol Depend. 2005 Nov 1;80(2):231-40. doi: 10.1016/j.drugalcdep.2005.04.004.
- Mertens JR, Flisher AJ, Satre DD, Weisner CM. The role of medical conditions and primary care services in 5-year substance use outcomes among chemical dependency treatment patients. Drug Alcohol Depend. 2008 Nov 1;98(1-2):45-53. doi: 10.1016/j.drugalcdep.2008.04.007. Epub 2008 Jun 20.
- Mertens JR, Weisner CM. Predictors of substance abuse treatment retention among women and men in an HMO. Alcohol Clin Exp Res. 2000 Oct;24(10):1525-33.
- Richter KP, Ahluwalia HK, Mosier MC, Nazir N, Ahluwalia JS. A population-based study of cigarette smoking among illicit drug users in the United States. Addiction. 2002 Jul;97(7):861-9. doi: 10.1046/j.1360-0443.2002.00162.x.
- Fleming MF, Mundt MP, French MT, Manwell LB, Stauffacher EA, Barry KL. Benefit-cost analysis of brief physician advice with problem drinkers in primary care settings. Med Care. 2000 Jan;38(1):7-18. doi: 10.1097/00005650-200001000-00003.
- Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAMA. 2002 Oct 9;288(14):1775-9. doi: 10.1001/jama.288.14.1775.
- Schmittdiel J, Mosen DM, Glasgow RE, Hibbard J, Remmers C, Bellows J. Patient Assessment of Chronic Illness Care (PACIC) and improved patient-centered outcomes for chronic conditions. J Gen Intern Med. 2008 Jan;23(1):77-80. doi: 10.1007/s11606-007-0452-5. Epub 2007 Nov 21.
- Mosen DM, Schmittdiel J, Hibbard J, Sobel D, Remmers C, Bellows J. Is patient activation associated with outcomes of care for adults with chronic conditions? J Ambul Care Manage. 2007 Jan-Mar;30(1):21-9. doi: 10.1097/00004479-200701000-00005.
- Street RL Jr. Gender differences in health care provider-patient communication: are they due to style, stereotypes, or accommodation? Patient Educ Couns. 2002 Dec;48(3):201-6. doi: 10.1016/s0738-3991(02)00171-4.
- McKay JR. Is there a case for extended interventions for alcohol and drug use disorders? Addiction. 2005 Nov;100(11):1594-610. doi: 10.1111/j.1360-0443.2005.01208.x.
- Von Korff M, Gruman J, Schaefer J, Curry SJ, Wagner EH. Collaborative management of chronic illness. Ann Intern Med. 1997 Dec 15;127(12):1097-102. doi: 10.7326/0003-4819-127-12-199712150-00008.
- Satre DD, Mertens J, Arean PA, Weisner C. Contrasting outcomes of older versus middle-aged and younger adult chemical dependency patients in a managed care program. J Stud Alcohol. 2003 Jul;64(4):520-30. doi: 10.15288/jsa.2003.64.520.
- Satre DD, Mertens JR, Arean PA, Weisner C. Five-year alcohol and drug treatment outcomes of older adults versus middle-aged and younger adults in a managed care program. Addiction. 2004 Oct;99(10):1286-97. doi: 10.1111/j.1360-0443.2004.00831.x.
- McLellan AT, Alterman AI, Metzger DS, Grissom GR, Woody GE, Luborsky L, O'Brien CP. Similarity of outcome predictors across opiate, cocaine, and alcohol treatments: role of treatment services. J Consult Clin Psychol. 1994 Dec;62(6):1141-58. doi: 10.1037//0022-006x.62.6.1141.
- Saitz R, Horton NJ, Larson MJ, Winter M, Samet JH. Primary medical care and reductions in addiction severity: a prospective cohort study. Addiction. 2005 Jan;100(1):70-8. doi: 10.1111/j.1360-0443.2005.00916.x.
- Tsuang MT, Lyons MJ, Eisen SA, Goldberg J, True W, Lin N, Meyer JM, Toomey R, Faraone SV, Eaves L. Genetic influences on DSM-III-R drug abuse and dependence: a study of 3,372 twin pairs. Am J Med Genet. 1996 Sep 20;67(5):473-7. doi: 10.1002/(SICI)1096-8628(19960920)67:53.0.CO;2-L.
- Schuckit MA, Smith TL. An 8-year follow-up of 450 sons of alcoholic and control subjects. Arch Gen Psychiatry. 1996 Mar;53(3):202-10. doi: 10.1001/archpsyc.1996.01830030020005.
- Dennis M, Scott CK. Managing addiction as a chronic condition. Addict Sci Clin Pract. 2007 Dec;4(1):45-55. doi: 10.1151/ascp074145.
- Dennis ML, Scott CK, Funk R, Foss MA. The duration and correlates of addiction and treatment careers. J Subst Abuse Treat. 2005;28 Suppl 1:S51-62. doi: 10.1016/j.jsat.2004.10.013.
- Weisner C, Ray GT, Mertens JR, Satre DD, Moore C. Short-term alcohol and drug treatment outcomes predict long-term outcome. Drug Alcohol Depend. 2003 Sep 10;71(3):281-94. doi: 10.1016/s0376-8716(03)00167-4.
- Hser YI, Anglin MD, Grella C, Longshore D, Prendergast ML. Drug treatment careers. A conceptual framework and existing research findings. J Subst Abuse Treat. 1997 Nov-Dec;14(6):543-58. doi: 10.1016/s0740-5472(97)00016-0.
- Holman H, Lorig K. Patients as partners in managing chronic disease. Partnership is a prerequisite for effective and efficient health care. BMJ. 2000 Feb 26;320(7234):526-7. doi: 10.1136/bmj.320.7234.526. No abstract available.
- Wagner EH, Austin BT, Von Korff M. Improving outcomes in chronic illness. Manag Care Q. 1996 Spring;4(2):12-25.
- McKay JR, Carise D, Dennis ML, Dupont R, Humphreys K, Kemp J, Reynolds D, White W, Armstrong R, Chalk M, Haberle B, McLellan T, O'Connor G, Pakull B, Schwartzlose J. Extending the benefits of addiction treatment: practical strategies for continuing care and recovery. J Subst Abuse Treat. 2009 Mar;36(2):127-30. doi: 10.1016/j.jsat.2008.10.005. No abstract available.
- McKay JR. Continuing care research: what we have learned and where we are going. J Subst Abuse Treat. 2009 Mar;36(2):131-45. doi: 10.1016/j.jsat.2008.10.004.
- McKay JR, Carise D. State of the science: Extending the benefits of addiction treatment. J Subst Abuse Treat. 2009 Mar;36(2):172-3. doi: 10.1016/j.jsat.2008.10.007. No abstract available.
- McKay JR, Lynch KG, Shepard DS, Pettinati HM. The effectiveness of telephone-based continuing care for alcohol and cocaine dependence: 24-month outcomes. Arch Gen Psychiatry. 2005 Feb;62(2):199-207. doi: 10.1001/archpsyc.62.2.199.
- Grella CE, Greenwell L. Treatment needs and completion of community-based aftercare among substance-abusing women offenders. Womens Health Issues. 2007 Jul-Aug;17(4):244-55. doi: 10.1016/j.whi.2006.11.005. Epub 2007 Jun 4.
- Godley SH, Godley MD, Wright KL, Funk RR, Petry NM. Contingent reinforcement of personal goal activities for adolescents with substance use disorders during post-residential continuing care. Am J Addict. 2008 Jul-Aug;17(4):278-86. doi: 10.1080/10550490802138798.
- Godley MD, Godley SH, Dennis ML, Funk R, Passetti LL. Preliminary outcomes from the assertive continuing care experiment for adolescents discharged from residential treatment. J Subst Abuse Treat. 2002 Jul;23(1):21-32. doi: 10.1016/s0740-5472(02)00230-1.
- Godley MD, Godley SH, Dennis ML, Funk RR, Passetti LL. The effect of assertive continuing care on continuing care linkage, adherence and abstinence following residential treatment for adolescents with substance use disorders. Addiction. 2007 Jan;102(1):81-93. doi: 10.1111/j.1360-0443.2006.01648.x.
- Ritsher JB, McKellar JD, Finney JW, Otilingam PG, Moos RH. Psychiatric comorbidity, continuing care and mutual help as predictors of five-year remission from substance use disorders. J Stud Alcohol. 2002 Nov;63(6):709-15. doi: 10.15288/jsa.2002.63.709.
- Friedmann PD, Saitz R, Samet JH. Management of adults recovering from alcohol or other drug problems: relapse prevention in primary care. JAMA. 1998 Apr 15;279(15):1227-31. doi: 10.1001/jama.279.15.1227.
- Friedmann PD, Hendrickson JC, Gerstein DR, Zhang Z, Stein MD. Do mechanisms that link addiction treatment patients to primary care influence subsequent utilization of emergency and hospital care? Med Care. 2006 Jan;44(1):8-15. doi: 10.1097/01.mlr.0000188913.50489.77.
- Friedmann PD, Zhang Z, Hendrickson J, Stein MD, Gerstein DR. Effect of primary medical care on addiction and medical severity in substance abuse treatment programs. J Gen Intern Med. 2003 Jan;18(1):1-8. doi: 10.1046/j.1525-1497.2003.10601.x.
- Umbricht-Schneiter A, Ginn DH, Pabst KM, Bigelow GE. Providing medical care to methadone clinic patients: referral vs on-site care. Am J Public Health. 1994 Feb;84(2):207-10. doi: 10.2105/ajph.84.2.207.
- Samet JH, Larson MJ, Horton NJ, Doyle K, Winter M, Saitz R. Linking alcohol- and drug-dependent adults to primary medical care: a randomized controlled trial of a multi-disciplinary health intervention in a detoxification unit. Addiction. 2003 Apr;98(4):509-16. doi: 10.1046/j.1360-0443.2003.00328.x.
- Saitz R, Larson MJ, Horton NJ, Winter M, Samet JH. Linkage with primary medical care in a prospective cohort of adults with addictions in inpatient detoxification: room for improvement. Health Serv Res. 2004 Jun;39(3):587-606. doi: 10.1111/j.1475-6773.2004.00246.x.
- Stein MD. Medical consequences of substance abuse. Psychiatr Clin North Am. 1999 Jun;22(2):351-70. doi: 10.1016/s0193-953x(05)70081-2.
- Chou SP, Grant BF, Dawson DA. Medical consequences of alcohol consumption--United States, 1992. Alcohol Clin Exp Res. 1996 Nov;20(8):1423-9. doi: 10.1111/j.1530-0277.1996.tb01144.x.
- Redelmeier DA, Tan SH, Booth GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med. 1998 May 21;338(21):1516-20. doi: 10.1056/NEJM199805213382106.
- Gonzales JJ, Insel TR. The conundrum of co-occurring mental and substance use disorders: opportunities for research. Biol Psychiatry. 2004 Nov 15;56(10):723-5. doi: 10.1016/j.biopsych.2004.09.007. No abstract available.
- Volkow ND. The reality of comorbidity: depression and drug abuse. Biol Psychiatry. 2004 Nov 15;56(10):714-7. doi: 10.1016/j.biopsych.2004.07.007. No abstract available.
- Montoya ID. Infectious diseases and anemia in a sample of out-of-treatment drug users. Am J Manag Care. 1998 Sep;4(9):1257-64.
- Moos RH, Brennan PL, Mertens JR. Diagnostic subgroups and predictors of one-year re-admission among late-middle-aged and older substance abuse patients. J Stud Alcohol. 1994 Mar;55(2):173-83. doi: 10.15288/jsa.1994.55.173.
- Bobo JK, Lando HA, Walker RD, McIlvain HE. Predictors of tobacco quit attempts among recovering alcoholics. J Subst Abuse. 1996;8(4):431-43. doi: 10.1016/s0899-3289(96)90004-8.
- Compton WM, Thomas YF, Stinson FS, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2007 May;64(5):566-76. doi: 10.1001/archpsyc.64.5.566.
- Kalman D. Smoking cessation treatment for substance misusers in early recovery: a review of the literature and recommendations for practice. Subst Use Misuse. 1998 Aug;33(10):2021-47. doi: 10.3109/10826089809069815.
- Friedmann PD, Jiang L, Richter KP. Cigarette smoking cessation services in outpatient substance abuse treatment programs in the United States. J Subst Abuse Treat. 2008 Mar;34(2):165-72. doi: 10.1016/j.jsat.2007.02.006. Epub 2007 May 23.
- Ziedonis DM, Guydish J, Williams J, Steinberg M, Foulds J. Barriers and solutions to addressing tobacco dependence in addiction treatment programs. Alcohol Res Health. 2006;29(3):228-35.
- Bobo JK, Davis CM. Recovering staff and smoking in chemical dependency programs in rural Nebraska. J Subst Abuse Treat. 1993 Mar-Apr;10(2):221-7. doi: 10.1016/0740-5472(93)90047-6.
- Fuller BE, Guydish J, Tsoh J, Reid MS, Resnick M, Zammarelli L, Ziedonis DM, Sears C, McCarty D. Attitudes toward the integration of smoking cessation treatment into drug abuse clinics. J Subst Abuse Treat. 2007 Jan;32(1):53-60. doi: 10.1016/j.jsat.2006.06.011. Epub 2006 Sep 26.
- Myers MG, MacPherson L. Smoking cessation efforts among substance abusing adolescents. Drug Alcohol Depend. 2004 Feb 7;73(2):209-13. doi: 10.1016/j.drugalcdep.2003.09.008.
- Hurt RD, Patten CA. Treatment of tobacco dependence in alcoholics. Recent Dev Alcohol. 2003;16:335-59. doi: 10.1007/0-306-47939-7_23.
- Satre DD, Gordon NP, Weisner C. Alcohol consumption, medical conditions, and health behavior in older adults. Am J Health Behav. 2007 May-Jun;31(3):238-48. doi: 10.5555/ajhb.2007.31.3.238.
- Hser YI, McCarthy WJ, Anglin MD. Tobacco use as a distal predictor of mortality among long-term narcotics addicts. Prev Med. 1994 Jan;23(1):61-9. doi: 10.1006/pmed.1994.1009.
- Hurt RD, Offord KP, Croghan IT, Gomez-Dahl L, Kottke TE, Morse RM, Melton LJ 3rd. Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort. JAMA. 1996 Apr 10;275(14):1097-103. doi: 10.1001/jama.275.14.1097. Erratum In: JAMA 1996 Sep 11;276(10):784.
- Booth BM, Blow FC, Cook CA, Bunn JY, Fortney JC. Relationship between inpatient alcoholism treatment and longitudinal changes in health care utilization. J Stud Alcohol. 1997 Nov;58(6):625-37. doi: 10.15288/jsa.1997.58.625.
- Skog OJ, Duckert F. The development of alcoholics' and heavy drinkers' consumption: a longitudinal study. J Stud Alcohol. 1993 Mar;54(2):178-88. doi: 10.15288/jsa.1993.54.178.
- Booth BM, Yates WR, Petty F, Brown K. Patient factors predicting early alcohol-related readmissions for alcoholics: role of alcoholism severity and psychiatric co-morbidity. J Stud Alcohol. 1991 Jan;52(1):37-43. doi: 10.15288/jsa.1991.52.37.
- Moos RH, Mertens JR, Brennan PL. Rates and predictors of four-year readmission among late-middle-aged and older substance abuse patients. J Stud Alcohol. 1994 Sep;55(5):561-70. doi: 10.15288/jsa.1994.55.561.
- Phibbs CS, Swindle RW, Recine B. Does case mix matter for substance abuse treatment? A comparison of observed and case mix-adjusted readmission rates for inpatient substance abuse treatment in the Department of Veterans Affairs. Health Serv Res. 1997 Feb;31(6):755-71.
- Brennan PL, Kagay CR, Geppert JJ, Moos RH. Elderly Medicare inpatients with substance use disorders: characteristics and predictors of hospital readmissions over a four-year interval. J Stud Alcohol. 2000 Nov;61(6):891-5. doi: 10.15288/jsa.2000.61.891.
- Ornstein P, Cherepon JA. Demographic variables as predictors of alcoholism treatment outcome. J Stud Alcohol. 1985 Sep;46(5):425-32. doi: 10.15288/jsa.1985.46.425.
- Street RL Jr, Gordon HS, Ward MM, Krupat E, Kravitz RL. Patient participation in medical consultations: why some patients are more involved than others. Med Care. 2005 Oct;43(10):960-9. doi: 10.1097/01.mlr.0000178172.40344.70.
- Kaplan SH, Gandek B, Greenfield S, Rogers W, Ware JE. Patient and visit characteristics related to physicians' participatory decision-making style. Results from the Medical Outcomes Study. Med Care. 1995 Dec;33(12):1176-87. doi: 10.1097/00005650-199512000-00002.
- Nease RF Jr, Brooks WB. Patient desire for information and decision making in health care decisions: the Autonomy Preference Index and the Health Opinion Survey. J Gen Intern Med. 1995 Nov;10(11):593-600. doi: 10.1007/BF02602742.
- Cooper LA, Gonzales JJ, Gallo JJ, Rost KM, Meredith LS, Rubenstein LV, Wang NY, Ford DE. The acceptability of treatment for depression among African-American, Hispanic, and white primary care patients. Med Care. 2003 Apr;41(4):479-89. doi: 10.1097/01.MLR.0000053228.58042.E4.
- Cooper-Patrick L, Gallo JJ, Powe NR, Steinwachs DM, Eaton WW, Ford DE. Mental health service utilization by African Americans and Whites: the Baltimore Epidemiologic Catchment Area Follow-Up. Med Care. 1999 Oct;37(10):1034-45. doi: 10.1097/00005650-199910000-00007.
- Johnson RL, Roter D, Powe NR, Cooper LA. Patient race/ethnicity and quality of patient-physician communication during medical visits. Am J Public Health. 2004 Dec;94(12):2084-90. doi: 10.2105/ajph.94.12.2084.
- Dawson DA, Grant BF. Gender effects in diagnosing alcohol abuse and dependence. J Clin Psychol. 1993 Mar;49(2):298-307. doi: 10.1002/1097-4679(199303)49:23.0.co;2-z.
- Booth BM, McLaughlin YS. Barriers to and need for alcohol services for women in rural populations. Alcohol Clin Exp Res. 2000 Aug;24(8):1267-75.
- Roman PM. Biological features of women's alcohol use: a review. Public Health Rep. 1988 Nov-Dec;103(6):628-37.
- Hser YI, Anglin MD, McGlothlin W. Sex differences in addict careers. 1. Initiation of use. Am J Drug Alcohol Abuse. 1987;13(1-2):33-57. doi: 10.3109/00952998709001499.
- Hser YI, Anglin MD, Booth MW. Sex differences in addict careers. 3. Addiction. Am J Drug Alcohol Abuse. 1987;13(3):231-51. doi: 10.3109/00952998709001512.
- Anglin MD, Hser YI, Booth MW. Sex differences in addict careers. 4. Treatment. Am J Drug Alcohol Abuse. 1987;13(3):253-80. doi: 10.3109/00952998709001513.
- Marsh JC, Cao D, D'Aunno T. Gender differences in the impact of comprehensive services in substance abuse treatment. J Subst Abuse Treat. 2004 Dec;27(4):289-300. doi: 10.1016/j.jsat.2004.08.004.
- Clayton RR. Multiple drug use. Epidemiology, correlates, and consequences. Recent Dev Alcohol. 1986;4:7-38.
- Kania J, Kofoed L. Drug use by alcoholics in outpatient treatment. Am J Drug Alcohol Abuse. 1984;10(4):529-34. doi: 10.3109/00952998409001490.
- Hubbard RL. Treating combined alcohol and drug abuse in community-based programs. Recent Dev Alcohol. 1990;8:273-83.
- Weisner C. The merging of alcohol and drug treatment: a policy review. J Public Health Policy. 1992 Spring;13(1):66-80.
- Moos RH, Mertens JR, Brennan PL. Patterns of diagnosis and treatment among late-middle-aged and older substance abuse patients. J Stud Alcohol. 1993 Jul;54(4):479-87. doi: 10.15288/jsa.1993.54.479.
- Tam TW, Weisner C, Mertens J. Demographic characteristics, life context, and patterns of substance use among alcohol-dependent treatment clients in a health maintenance organization. Alcohol Clin Exp Res. 2000 Dec;24(12):1803-10.
- Liberto JG, Oslin DW, Ruskin PE. Alcoholism in older persons: a review of the literature. Hosp Community Psychiatry. 1992 Oct;43(10):975-84. doi: 10.1176/ps.43.10.975.
- Oslin DW. Alcohol use in late life: disability and comorbidity. J Geriatr Psychiatry Neurol. 2000 Fall;13(3):134-40. doi: 10.1177/089198870001300307.
- Lemke S, Moos RH. Prognosis of older patients in mixed-age alcoholism treatment programs. J Subst Abuse Treat. 2002 Jan;22(1):33-43. doi: 10.1016/s0740-5472(01)00209-4.
- Oslin DW, Pettinati H, Volpicelli JR. Alcoholism treatment adherence: older age predicts better adherence and drinking outcomes. Am J Geriatr Psychiatry. 2002 Nov-Dec;10(6):740-7.
- Kashner TM, Rodell DE, Ogden SR, Guggenheim FG, Karson CN. Outcomes and costs of two VA inpatient treatment programs for older alcoholic patients. Hosp Community Psychiatry. 1992 Oct;43(10):985-9. doi: 10.1176/ps.43.10.985.
- Rice C, Longabaugh R, Beattie M, Noel N. Age group differences in response to treatment for problematic alcohol use. Addiction. 1993 Oct;88(10):1369-75. doi: 10.1111/j.1360-0443.1993.tb02023.x.
- Gfroerer J, Penne M, Pemberton M, Folsom R. Substance abuse treatment need among older adults in 2020: the impact of the aging baby-boom cohort. Drug Alcohol Depend. 2003 Mar 1;69(2):127-35. doi: 10.1016/s0376-8716(02)00307-1.
- Weisner C, Matzger H, Tam T, Schmidt L. Who goes to alcohol and drug treatment? Understanding utilization within the context of insurance. J Stud Alcohol. 2002 Nov;63(6):673-82. doi: 10.15288/jsa.2002.63.673.
- Zeber JE, Copeland LA, Grazier KL. Serious mental illness, aging, and utilization patterns among veterans. Mil Med. 2006 Jul;171(7):619-26. doi: 10.7205/milmed.171.7.619.
- Hassan I, McCabe R, Priebe S. Professional-patient communication in the treatment of mental illness: a review. Commun Med. 2007;4(2):141-52. doi: 10.1515/CAM.2007.018.
- Holder HD, Blose JO. The reduction of health care costs associated with alcoholism treatment: a 14-year longitudinal study. J Stud Alcohol. 1992 Jul;53(4):293-302. doi: 10.15288/jsa.1992.53.293.
- Jerrell JM, Wieduwilt KM, Macey DV. Use and costs of public-sector behavioral health services for african-american and white women. Psychiatr Serv. 2002 Feb;53(2):195-200. doi: 10.1176/appi.ps.53.2.195.
- Fleming MF, Graham AW. Screening and brief interventions for alcohol use disorders in managed care settings. Recent Dev Alcohol. 2001;15:393-416. doi: 10.1007/978-0-306-47193-3_22.
- Fleming MF, Mundt MP, French MT, Manwell LB, Stauffacher EA, Barry KL. Brief physician advice for problem drinkers: long-term efficacy and benefit-cost analysis. Alcohol Clin Exp Res. 2002 Jan;26(1):36-43.
- Mendelson DN, Schwartz WB. The effects of aging and population growth on health care costs. Health Aff (Millwood). 1993 Spring;12(1):119-25. doi: 10.1377/hlthaff.12.1.119.
- Polder JJ, Bonneux L, Meerding WJ, van der Maas PJ. Age-specific increases in health care costs. Eur J Public Health. 2002 Mar;12(1):57-62. doi: 10.1093/eurpub/12.1.57.
- Seshamani M, Gray A. Health care expenditures and ageing: an international comparison. Appl Health Econ Health Policy. 2003;2(1):9-16.
- Samet JH, Friedmann P, Saitz R. Benefits of linking primary medical care and substance abuse services: patient, provider, and societal perspectives. Arch Intern Med. 2001 Jan 8;161(1):85-91. doi: 10.1001/archinte.161.1.85.
- Gordon AJ, Fiellin DA, Friedmann PD, Gourevitch MN, Kraemer KL, Arnsten JH, Saitz R; Society of General Internal Medicine's Substance Abuse Interest Group. Update in addiction medicine for the primary care clinician. J Gen Intern Med. 2008 Dec;23(12):2112-6. doi: 10.1007/s11606-008-0806-7. Epub 2008 Oct 2. No abstract available.
- Gordon AJ, Sullivan LE, Alford DP, Arnsten JH, Gourevitch MN, Kertesz SG, Kunins HV, Merrill JO, Samet JH, Fiellin DA. Update in addiction medicine for the generalist. J Gen Intern Med. 2007 Aug;22(8):1190-4. doi: 10.1007/s11606-007-0133-4. Epub 2007 May 10. No abstract available.
- Sellers EM, Ciraulo DA, DuPont RL, Griffiths RR, Kosten TR, Romach MK, Woody GE. Alprazolam and benzodiazepine dependence. J Clin Psychiatry. 1993 Oct;54 Suppl:64-75; discussion 76-7.
- Iturralde E, Weisner CM, Adams SR, Chi FW, Ross TB, Cunningham SF, Ghadiali M, Asyyed AH, Satre DD, Campbell CI, Sterling SA. Patterns of Health Care Use 5 Years After an Intervention Linking Patients in Addiction Treatment With a Primary Care Practitioner. JAMA Netw Open. 2022 Nov 1;5(11):e2241338. doi: 10.1001/jamanetworkopen.2022.41338.
- Weisner CM, Chi FW, Lu Y, Ross TB, Wood SB, Hinman A, Pating D, Satre D, Sterling SA. Examination of the Effects of an Intervention Aiming to Link Patients Receiving Addiction Treatment With Health Care: The LINKAGE Clinical Trial. JAMA Psychiatry. 2016 Aug 1;73(8):804-14. doi: 10.1001/jamapsychiatry.2016.0970.
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart
1 mars 2011
Primärt slutförande (Förväntat)
31 december 2025
Avslutad studie (Förväntat)
31 december 2025
Studieregistreringsdatum
Först inskickad
11 juni 2012
Först inskickad som uppfyllde QC-kriterierna
13 juni 2012
Första postat (Uppskatta)
18 juni 2012
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
26 april 2023
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
25 april 2023
Senast verifierad
1 april 2023
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 10-01606
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Koppla patientaktiveringsintervention
-
Massachusetts General HospitalNational Institute on Minority Health and Health Disparities (NIMHD)AvslutadMentala störningarFörenta staterna, Puerto Rico
-
University of Mississippi Medical CenterAvslutadDepression | Astma | UrtikariaFörenta staterna
-
Boston Medical CenterNortheastern UniversityAvslutadFörberedelsevårdFörenta staterna
-
Sykehuset i Vestfold HFHospital Pharmacy Enterprise, South Eastern NorwayAvslutadÅldrande | Höftfrakturer | Patient FallNorge
-
University of Colorado, DenverNational Institute of Nursing Research (NINR); Kaiser Permanente; Denver...AvslutadPalliativ vårdFörenta staterna
-
Debra FriedmanNational Cancer Institute (NCI)Aktiv, inte rekryterande
-
Vanderbilt University Medical CenterNational Institute on Aging (NIA)AvslutadPolyfarmaci | Geriatriska syndrom | VårdövergångarFörenta staterna
-
Shifa Tameer-e-Millat UniversityAvslutad
-
Georgia Institute of TechnologyNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) och andra samarbetspartnersAvslutadTyp 2 diabetes mellitusFörenta staterna